Multivariate logistic regression model in estimating the association between deletion of chromosome 9 and complete response, considering other covariates in the model
Variable . | Parameter estimate . | Standard error . | P . | Odds ratio . |
---|---|---|---|---|
Age, 60 y and older vs less than 60 y | -0.68 | 0.28 | .015 | 0.51 |
Spleen, more than 0 cm vs 0 cm BCM | -0.75 | 0.36 | .038 | 0.47 |
PB blasts, more than 0% vs 0 % | -1.24 | 0.54 | .021 | 0.29 |
Ph+ at start, 90% or greater vs less than 90% | -1.17 | 0.49 | .017 | 0.31 |
Stage, CP untreated vs CP IFN failure | 1.02 | 0.34 | .003 | 2.77 |
Stage, AP vs CP IFN failure | 1.15 | 0.63 | .068 | 3.15 |
Dosage, 800 mg vs 400 mg | 1.03 | 0.36 | .004 | 2.81 |
Der(9) deletions | -0.33 | 0.47 | .48 | 0.72 |
Variable . | Parameter estimate . | Standard error . | P . | Odds ratio . |
---|---|---|---|---|
Age, 60 y and older vs less than 60 y | -0.68 | 0.28 | .015 | 0.51 |
Spleen, more than 0 cm vs 0 cm BCM | -0.75 | 0.36 | .038 | 0.47 |
PB blasts, more than 0% vs 0 % | -1.24 | 0.54 | .021 | 0.29 |
Ph+ at start, 90% or greater vs less than 90% | -1.17 | 0.49 | .017 | 0.31 |
Stage, CP untreated vs CP IFN failure | 1.02 | 0.34 | .003 | 2.77 |
Stage, AP vs CP IFN failure | 1.15 | 0.63 | .068 | 3.15 |
Dosage, 800 mg vs 400 mg | 1.03 | 0.36 | .004 | 2.81 |
Der(9) deletions | -0.33 | 0.47 | .48 | 0.72 |
BCM indicates below costal margin; PB, peripheral blood; CP, chronic phase; AP, accelerated phase; and IFN-α, interferon alpha.